Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rockwell Medical In (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 295,032
  • Shares Outstanding, K 51,760
  • Annual Sales, $ 53,280 K
  • Annual Income, $ -19,800 K
  • 36-Month Beta 2.02
  • Price/Sales 5.40
  • Price/Cash Flow N/A
  • Price/Book 7.23

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.55 +6.67%
on 01/02/18
6.27 -5.58%
on 12/20/17
-0.26 (-4.21%)
since 12/19/17
3-Month
5.43 +9.12%
on 11/08/17
7.40 -20.00%
on 10/20/17
-1.04 (-14.94%)
since 10/19/17
52-Week
5.06 +17.00%
on 01/23/17
8.98 -34.08%
on 05/01/17
+0.22 (+3.86%)
since 01/19/17

Most Recent Stories

More News
New Research Coverage Highlights ConnectOne, Rockwell Medical, Accelerate Diagnostics, Eleven Biotherapeutics, Renasant, and Natera -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ConnectOne Bancorp, Inc. (NASDAQ:CNOB),...

CNOB : 28.80 (-0.17%)
NTRA : 11.11 (+7.86%)
EBIO : 0.82 (+1.23%)
AXDX : 28.25 (+1.44%)
RMTI : 5.92 (+3.86%)
RNST : 44.04 (+1.38%)
Range Resources Set to Possibly Pullback After Yesterday's Rally of 3.11%

Range Resources (NYSE:RRC) traded in a range yesterday that spanned from a low of $17.37 to a high of $17.95. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $17.87...

RRC : 16.08 (-2.37%)
RMTI : 5.92 (+3.86%)
Rockwell Medical Set to Possibly Pullback After Yesterday's Rally of 4.07%

Rockwell Medical (NASDAQ:RMTI) traded in a range yesterday that spanned from a low of $5.91 to a high of $6.25. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of...

RMTI : 5.92 (+3.86%)
Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic(R) in Peru

- Estimated Market Launch 2-half 2018 Provides Access to 13,000 Dialysis Patients -

RMTI : 5.92 (+3.86%)
Rockwell Medical Reports Third Quarter Results

Conference Call and Webcast Today at 4:30 p.m. EST.

RMTI : 5.92 (+3.86%)
Rockwell Medical Schedules Third Quarter 2017 Earnings Call

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

RMTI : 5.92 (+3.86%)
Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting

Rockwell Medical, Inc. (NASDAQ:RMTI), announced today that two poster presentations for Triferic have been selected by the American Society of Nephrology (ASN) for presentation at the annual Kidney Week...

RMTI : 5.92 (+3.86%)
Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA

Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on the commercial launch of Calcitriol, stating that the FDA has requested extra time to review its post-approval drug manufacturing submission...

RMTI : 5.92 (+3.86%)
Rockwell Files Calcitriol Post-Approval Manufacturing Submission with FDA

Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on the commercial launch of Calcitriol, stating that it has submitted its chemistry, manufacturing and controls (CMC) post-approval drug manufacturing...

RMTI : 5.92 (+3.86%)
Rockwell Medical Updates Progress on Calcitriol Commercial Launch

Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on the commercial launch of Calcitriol, stating that product stability data for manufacturing approval is suitable for submission to the FDA....

RMTI : 5.92 (+3.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

2nd Resistance Point 6.21
1st Resistance Point 6.06
Last Price 5.92
1st Support Level 5.70
2nd Support Level 5.49

See More

52-Week High 8.98
Fibonacci 61.8% 7.48
Fibonacci 50% 7.02
Fibonacci 38.2% 6.56
Last Price 5.92
52-Week Low 5.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.